Dr. Lark Greenwald Guss, MD

Dr. Guss practices at Clinic 5C in Spokane, Washington.

Dr. Guss' NPI, 1275973398, was assigned on July 3, 2013. Dr. Guss graduated from Johns Hopkins University School of Medicine in 2013. Dr. Guss holds Washington license MD60840220.

Dr. Guss' primary practice is Clinic 5C, at 510 S Cowley St Ste 201, Spokane, WA 99202. The practice phone is (509) 456-8444.

Dr. Guss' primary practice is Clinic 5C in Spokane, Washington. The medical group on file is Dermatology Specialists of Spokane. Dmand AI also links Dr. Guss to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guss practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Guss' primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dmand AI has Dr. Guss' licenses on file in 3 states: Washington, California and Montana.

CMS data shows 1,483 Medicare services from Dr. Guss across 25 procedure codes in 2024, for 498 Medicare patients. Medicare paid $432,557 for them. Every service was in an office.

CMS counts 498 Medicare patients who saw Dr. Guss in 2024. The largest group is 75 to 84, with 216 patients. 65% of them have high cholesterol, and 63% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Guss' median patient age at 74, with 47% women.

In 2024, Dr. Guss wrote 99 Medicare Part D claims for 69 patients. 99% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $268 in total drug cost. In 2023, CMS named 50 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Guss for performance year 2024, reported as part of a group. Dr. Guss accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 205 procedures of melanoma (skin cancer) excision by Dr. Guss, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Guss, published from 2016 to 2019. The most frequent topics are Laser Therapy, Rejuvenation and Skin Aging. Dr. Guss has published most often in Dermatol Surg. Dr. Guss' most frequent co-authors are Joanna Grace Bolton, MD, Sabrina Guillen Fabi, MD and Mitchel Paul Goldman, MD.

Dmand AI links Dr. Guss to 1 clinical trial. Conditions studied include Pachyonychia Congenita and Epidermolysis Bullosa Simplex.

CMS Open Payments shows 71 general payments to Dr. Guss from 22 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $352.

Dr. Guss graduated from Johns Hopkins University School of Medicine in 2013.